INTERNATIONAL PATENT: BOOSTIMMUNE, INC., 주식회사 부스트이뮨, THE ASAN FOUNDATION, 재단법인 아산사회복지재단 FILES APPLICATION FOR "PLASMA TCTP AS BIOMARKER INDICATIVE OF CANCER TREATMENT RESPONSIVENESS"

Posted On: 2026-02-10

GENEVA, Feb. 10 -- BOOSTIMMUNE, INC. (6th Floor, 36 Nambusunhwan-ro 350-gil,Seocho-gu,Seoul 06736), 주식회사 부스트이뮨 (서울특별시서초구남부순환로350길 36, 6층), THE ASAN FOUNDATION (88, Olympic-ro 43-gil,Songpa-gu,Seoul 05505), 재단법인 아산사회복지재단 (서울특별시송파구올림픽로43길 88) filed a patent application (PCT/KR2025/011416) for "PLASMA TCTP AS BIOMARKER INDICATIVE OF CANCER TREATMENT RESPONSIVENESS" on Jul 31, 2025. With publication no. WO/2...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

INTERNATIONAL PATENT: BOOSTIMMUNE, INC., 주식회사 부스트이뮨, THE ASAN FOUNDATION, 재단법인 아산사회복지재단 FILES APPLICATION FOR "PLASMA TCTP AS BIOMARKER INDICATIVE OF CANCER TREATMENT RESPONSIVENESS"